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questionnaire. Whatever the level of pain reduction, the WTP value evaluated was 
different before and after surgery. The WTP were not correlated to the patients’ 
incomes. CONCLUSIONS: Although short-lived, avoidance of postoperative pain 
may have considerable value to patients undergoing a heavy surgery. These ﬁndings 
may have important consequences for selection of emerging analgesia technologies.
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OBJECTIVES: Inﬂuenza causes signiﬁcant morbidity and mortality particularly in the 
elderly where the vast majority of inﬂuenza related deaths occur among people aged 
q65 years of age. Vaccination is the most effective way to prevent inﬂuenza and its 
associated complications. Studies have shown that administering the inﬂuenza vaccine 
via the intradermal (ID) route results in signiﬁcantly superior immune responses 
compared with intramuscular (IM) administration. A WTP study using discrete choice 
conjoint analysis (CA) was designed to determine participant’s preference for ID 
inﬂuenza vaccination over the currently available IM injection. METHODS: Austra-
lians individuals aged 65 years and older were presented with a set of 12 pairs of 
choices describing the two vaccine types; 11 choices to determine WTP for variable 
levels and one to detect irrational trades. Each pair contained information for IM and 
ID vaccines regarding efﬁcacy, adverse event proﬁle, administration and cost. Values 
were randomly allocated based on the ranges for each attribute and each participant 
received a bespoke set of choices. The questionnaire sought basic demographic infor-
mation and was completed after a short presentation on inﬂuenza. RESULTS: Ninety 
people aged q65 years were recruited to participate in the study. Participants had an 
average age of 71.1 years (SD  4.0) and more than half (n  50, 56%) stated that 
they get immunised against inﬂuenza annually. Both the adjusted and unadjusted 
analyses for the CA showed a statistically signiﬁcant preference for ID injection with 
participants willing to pay an additional $25.80 for an ID vaccine and $26.80 when 
adjusted for demographic variables. The efﬁcacy difference of ID vs. IM was respon-
sible for driving preference and the ID needle also added to the overall WTP for the 
vaccine and was also statistically signiﬁcant. CONCLUSIONS: The participants 
clearly preferred to be vaccinated against inﬂuenza with an ID vaccine over an intra-
muscular vaccine.
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OBJECTIVES: To assess Canadian patient preferences and estimate willingness to 
pay for symptoms relief for gastroesophageal reﬂux disease (GERD) treatment. 
METHODS: The study was a cross-sectional design, recruiting patients enrolled in a 
multi-centre clinical trial from 17 Canadian clinical sites. Preferences and willingness 
to pay were estimated using a discrete choice experiment (DCE) informed by focus 
groups and clinical literature. The experimental design considered orthogonality, 
balance and efﬁciency. The pen-and-paper-administered DCE survey consisted of 14 
discrete choice tasks. Patients chose between 3 different GERD treatments described 
by 6 attributes: GERD medication cost, when medication was taken, diet changes, 
daytime discomfort due to GERD, sleeping discomfort due to GERD and side effects. 
Additional data were gathered on health status, health-related quality of life, and 
sociodemographic characteristics RESULTS: 361 of 379 subjects completed the DCE. 
Mean age was 57 years (S.D. 16); 48% were male; 41% paid some portion of prescrip-
tion drug costs; a majority rated their GERD symptoms as mild to moderate. Avoiding 
side effects was the most important attribute, followed by sleeping discomfort, daytime 
discomfort, dietary changes and medication cost. Treatment choice was least affected 
by when the medications were to be taken. Patients were willing to pay (WTP) $16 
for mild rather than moderate side effects and $14 for complete relief of nighttime 
symptoms rather than 1–3 episodes per month. Patients with less severe GERD symp-
toms were WTP more to avoid side effects. Older patients were less WTP for better 
relief than younger patients. Avoiding sleeping discomfort was more important to 
women. CONCLUSIONS: Patients are WTP more for a GERD medication that avoids 
side effects, nighttime and daytime discomfort and dietary changes. Differences in 
preferences were found by gender and age. This information can help to guide physi-
cians and patients in choosing GERD treatments.
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HEALTH CARE USE & POLICY STUDIES – Consumer Role in Health Care
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OBJECTIVES: Increased competition in the health sector has led hospitals and other 
care institutions to explore new allocation mechanisms that move away from tradi-
tional expert based care allocation to more commercially based allocation mecha-
nisms. Little is known however about consumer perceptions and evaluations of new 
commercial (price based) allocation mechanisms and how these perceptions and evalu-
ations may differ between individuals and treatments. This paper investigates how 
consumers evaluate (new) hospital care allocation mechanisms. METHODS: We used 
data of 577 respondents from an American consumer panel. To test the framework 
conﬁrmatory factor analysis was done and random parameter regression models were 
estimated. RESULTS: We found that offering individuals the opportunity to pay more 
for a higher chance of treatment (ﬂexible pricing) affects their perceptions of both the 
total (p  0.005) and distributional health outcomes (p  0.001) of a hospital’s care, 
which in turn affect consumer attitude towards the allocation mechanism (p  0.001 
and p  0.001). Furthermore, we found that the effects of these two key collective 
outcome perceptions on consumer attitude are moderated by the type of medical 
condition (life saving vs. life improving) (p  0.001 and p  0.003), by age (p  0.002 
and p  0.001), and to a lesser extent by gender (p  0.01 and n.s.). CONCLUSIONS: 
Knowing how consumers evaluate allocation mechanisms is important for hospitals 
because less acceptable allocation mechanisms may scare away patients and decrease 
community support towards the hospital. Therefore our ﬁndings can be relevant and 
helpful for hospitals that consider implementing new allocation policies.
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OBJECTIVES: Frequent attenders (FA) generate a large proportion of clinical work-
load, referrals and prescriptions in the primary care (PC). The aim of this study was 
to examine factors, which predict frequent attendance of the PC services in a long-term 
follow-up. Factors explaining the long-term frequent use of PC services have not been 
previously explored. METHODS: A prospective cohort study without intervention 
was carried out in the primary health care centre in Tampere, Finland. From a random 
sample of 200 PC FAs, 85 patients participated in the study. All participants were PC 
FAs in the ﬁrst study year. After four years follow-up the patients were classiﬁed as 
persistent or temporary FAs. A patient was considered as a persistent FA, if he visited 
the health centre at least 8 times a year for at least 3 out of 4 follow up years. In 
addition to clinical assessment, also the patient reported outcome assessment was 
comprehensive including e.g. 15D, BDI, SOC-13, TAS-20, SCL (somatisation part), 
Whitely Index, patient satisfaction, fear of death, and alcohol consumption. 59 dif-
ferent variables were examined as potential predictors using P-course, a web-based 
Bayesian prediction tool. The models were assessed with accuracy, and predictions 
with posterior odds and credibility intervals. RESULTS: According to the predictions, 
the most inﬂuential predictive factors related to persistent FAs were female gender, 
body mass index above 30, former frequent attendance, fear of death, alcohol absti-
nence, low patient satisfaction and irritable bowel syndrome. New observations 
related to FAs were high body mass index, alcohol abstinence, fear of death and irri-
table bowel syndrome. CONCLUSIONS: Our Bayesian model can be used for proac-
tive modelling of persistent FAs in uncertain situations. However, before its use in 
practice, the external validity of the model will need to be deﬁned, because we only 
used partitioning in the accuracy assessments and not independent data.
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OBJECTIVES: The social security system in Austria constringes insured people to pay 
a ﬁxed co-payment of a4.80 per prescribed drug unit. Under certain conditions insured 
are exempted (e.g. very poor people). In 2008 the Austrian government implemented 
a co-payment limit for prescription drugs, called REGO. If the insured have paid 2% 
of their annual net income for co-payment rates, they are exempted from these co-
payments for the rest of the year. We analyzed the effects of REGO on the prescription 
volume and therewith demand and on the total expenditures for prescription drugs. 
METHODS: We estimated hypothetical expenditures and prescriptions for 2008 
under the assumption that REGO had not been implemented, using the historical data 
of 2006, 2007 and 2008 on different autoregressive process models. RESULTS: Our 
analysis showed that the demand increases when prescription drugs become free, and 
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therewith is price elastic. We estimate that approximately 40% of the increase in pre-
scription volume results from REGO. Additionally to the increase in expenditures the 
sickness funds are facing a loss of income as less co-payment rates are paid. Prescrip-
tions with prices lower than the co-payment rate are not paid by the insured anymore, 
but by the sickness funds. These low-price prescriptions cause a dramatic increase in 
volume, however, not a decisive increase in total expenditures. CONCLUSIONS: The 
time courses allow us to evaluate the effects of REGO. Furthermore they reveal 
information about the behaviour of the demand function, when the price drops to 
zero. The intention of REGO is to improve equity by protecting poorer and heavy 
users of prescription drugs from the ﬁnancial burden of co-payments. Demand 
increases, when REGO reduces the price for prescription drugs to a 0. This could 
indicate an improvement in equity and access, however, affects on efﬁciency have to 
be shown in further analysis.
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OBJECTIVES: The distribution of free samples to patients in the US, the retail value 
of which is US$20 billion annually, is controversial. Proponents assert that free 
samples improve medication access for low-income patients while opponents argue 
free sample availability drives the choice of expensive, brand-name pharmaceuticals. 
It is critical to shed light on the beneﬁts and costs of free samples for older adults, in 
particular, given their high drug cost burden. Our objective was to determine the 
proportion of older adults receiving free samples, and to examine the association 
between free sample receipt and communication with physicians and cost-related 
non-adherence to medicines. METHODS: In 2006, we conducted a national telephone 
survey of persons age 65 and older in the U.S., over-sampling those with low-incomes. 
The survey included several questions related to prescription drug insurance coverage, 
medication use and doctor-patient communication. RESULTS: Half of older adults 
surveyed had received free samples from their doctors at least once in the past 12 
months, with 21% receiving samples more than once. Two thirds of seniors who had 
talked to their doctor about the cost of medicines they are taking received free samples 
compared to 43% of those who did not have such discussions. Seniors who received 
free samples were less likely to agree there is nothing their doctor can do to help lower 
drug costs (40% vs. 47%) than those who did not receive samples. Free sample receipt 
was associated with a lower risk of cost-related non-adherence (failing to ﬁll prescrip-
tions, skipping or reducing doses due to cost) (31% vs. 26%). CONCLUSIONS: 
Receipt of free samples is common among older adults and appears to increase with 
discussions of drug costs between doctors and patients. Free sample receipt may help 
reduce cost-related non-adherence, however, further study is needed to shed light on 
these behaviors.
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OBJECTIVES: Our aim was to estimate the hospitalization length of stay (LOS) and 
risk of death within hospitalization, associated with the occurrence of post-operative 
residual curarization (PORC) and adverse events (AE) possibly or probably related 
to neuromuscular blockade reversal agents (NMBRA) use. METHODS: Data was 
obtained from hospitalizations occurring in Portuguese public hospitals in 2007. Surgi-
cal procedures from (ICD-9-CM CSP codes): central nervous (01–05), endocrine 
(06–07), respiratory (30–34), cardiovascular (35–39), hematologic and lymphatic 
(40–41) and digestive (42–54) systems were selected due to their high potential for 
NMBRA use. According to clinical expertise and ICD-9 diagnosis classiﬁcation, AE 
and events PORC were grouped into the following outcomes: bronchospasm, dyspha-
gia or dyspepsia, cardiac dysrhythmias, tachycardia, hypertension, hypotension, xero-
stomia, nausea, vomiting or abdominal pain, central nervous system complications 
and allergic, psychological, respiratory, sensation and visual disturbances. Data con-
sisted of admission and discharge date, age, gender, primary and secondary diagnosis, 
primary and secondary surgical procedures. No data was available regarding the type 
of NMBRA used. Within hospital, risk of death was estimated with parametric sur-
vival (Weibull) regression models. LOS was estimated through negative binomial 
regression models. RESULTS: The analysis included 136,150 surgical procedures 
(55.0% female and mean(SD) age 54.2(18.9) years). Rates of AE and PORC were 
25.5% and 3.0%, respectively. Crude death rate was 2.8%. The risk of death was 1.3 
(95%CI: 1.2–1.4) times higher in patients with AE and 2.0 (95%CI: 1.9–2.2) times 
higher in patients with PORC, adjusted for other covariates. The mean LOS was 5.3 
days (30 days, n  130,254). LOS was signiﬁcantly increased both in patients with 
at least one AE (2.2 days, 95%CI: 2.1–2.4) or at least one PORC event (7.4 days, 
95%CI: 6.7–8.2). CONCLUSIONS: Post-operative residual curarization and adverse 
events possibly or probably related to neuromuscular blockade reversal agents use are 
associated with increased inpatient death and extended hospital length of stay.
PHP6
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OBJECTIVES: The occupancy rate is a calculation to show the actual utilization of 
the inpatient health facility for a period. It is expressed as a percent. Our aim was to 
deﬁne occupancy rates between 2000 and 2008 in the Middle-European country, 
Hungary. Health care of its 10 million inhabitants was “secured” by 59.584 beds until 
31st March 2007 and by 43.943 beds afterwards. METHODS: To calculate the 
average occupancy rate for a typical one-year reporting period, two data items are 
needed. The “Inpatient Days of Care” and the “Bed Days Available”. Data were got 
from the National Health Insurance Fund Administration. To calculate occupancy 
rate the (Inpatient Days of Care / Bed Days Available) x 100 formula was used. 
RESULTS: The highest occupancy rate between 2000–2008 in Hungary was 76.3% 
in 2001. From that time the occupancy rate continuously decreased independently of 
the decrease of beds available. The ﬁgure reached 66.9% in 2007. In 2008 a slight 
increase could be seen (70.7%), which seemed not to be signiﬁcant, but in comparison 
to the decrease of beds (26%) at spring of 2007. Examining the gathered monthly 
data, it was realized that in February bed occupancy was the highest, 77.2%. Examin-
ing occupancy rate for calendar days, it got the highest ﬁgure on Thursday, 77%. In 
order to deﬁne how many beds are really needed, it has to be examined occupancy 
rate on every single calendar day. Evaluating the data it was observed that there were 
days when occupancy rate was higher than 91% but regularly reached 80%. CON-
CLUSIONS: On the basis of the above mentioned it can be proved that planning bed 
number, in addition to yearly average, the daily occupancy rate has to be considered, 
as stress on health care is highly ﬂuctuating due to unplanned, sudden cases.
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OBJECTIVES: Cost calculations show the importance of the utilisation of the capac-
ity. The aim of the study is to analyse the percentage of bed occupancy in the intensive 
care units in Hungary according to the Diagnosis related Groups (DRG) system. 
METHODS: Data were derived from the National Health Insurance Fund Administra-
tion (NHI). The bed occupancy rate of the ﬁrst eleven months of the year 2008 were 
analysed and compared to the mean of the Hungarian rate and to the means of two 
other recognized specialties. RESULTS: The number of beds was not ﬂuctuated 
throughout the examined eleven months. The bed capacity of the Hungarian hospitals 
was 48.6 beds per 10,000 people. 2.82% of the total hospitals beds, 1.37 beds per 
10,000 people, were in intensive care units. The departments of internal medicine had 
14.54% and the departments of surgery had 10.95% share in the Hungarian hospital 
beds. The percentage of occupancy of the intensive care units was 58.2%, of the 
departments of internal medicine was 75.63% and of the departments of surgery was 
65.29%. The total Hungarian hospitals occupancy ratio was 69.84%, more than 10% 
higher compared to the intensive units. CONCLUSIONS: Without the variable costs 
of the treatments, the outlay of an intensive care unit is remarkable. A better occu-
pancy of the intensive care units can increase the reimbursement for the hospitals or 
the decreases in the number of inpatient beds can be a cost-reduction strategy in the 
Hungarian Diagnosis-related Groups (DRG) ﬁnancing system.
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OBJECTIVES: The management of the large patient population chronically treated 
with oral anticoagulation therapy (OAT) poses organisational challenges that in Italy 
are traditionally approached with centralised procedures, relying on hospital-based 
clinics. However, the availability of near-patient testing devices for the monitoring of 
OAT effectiveness (INR measurement) allows for alternative or complementary man-
agement models (patient self-monitoring—PSM). PSM has been proven effective and 
safe, and could be attractive, especially in the perspective of the patient, whose life 
could be severely affected by the costs and times implied in the process of the OAT 
management. In order to assess PSM potential economic impact in Italy, there is a 
need for real-world economic and organisational data. This study was planned to 
investigate treatment patterns and to estimate the average costs borne by OAT patients 
in Italy. METHODS: A 19-item questionnaire, investigating the characteristics of the 
patient, his/her therapeutic regimens, the structures involved and the distances from 
home, the frequencies and the amount of time implied in the management of the OAT, 
